Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. News/
    3. Health & wellness/
    4. Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

    Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

    Helping Babies Breathe

    A quadruplet baby from the Shen family who needed neonatal resuscitation at birth

    Childbirth should be a moment to celebrate the miracle of life, but as many as 1 in 10 newborns are unable to breathe upon entering the world.

    The condition, known as birth asphyxia, is among the world’s leading causes of infant death. And a decade ago, it accounted for 20% of China’s infant mortality rate—that’s a shocking 73,000 babies lost each year.

    But a simple, low-tech medical technique called neonatal resuscitation can help prevent it. That’s why Johnson & Johnson partnered with the Chinese Ministry of Health and other organizations in an effort to ensure that caregivers in every Chinese hospital received the training they needed to administer the procedure.

    Ten years later, we’re proud to say that this unique public/private partnership, known as “Freedom of Breath, Fountain of Life,” has helped over 100,000 Chinese babies take their first breath. And after a decade of success, we’re committed to keeping the partnership going for another five years.

    But don’t just take our word for it: Watch the moving video below and meet six kids who are alive and thriving, thanks to the historic partnership that empowered everyone from midwives to doctors to save precious lives.

    More from Johnson & Johnson

    Striving for a cure for multiple myeloma: What HCPs need to know

    Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

    The future of immunology

    Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

    What is inflammation?

    Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.